- Home
- BSRR vs RGNX Comparison
BSRR vs RGNX Comparison
Compare BSRR & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSRR
- RGNX
- Stock Information
- Founded
- BSRR 1977
- RGNX 2008
- Country
- BSRR United States
- RGNX United States
- Employees
- BSRR N/A
- RGNX N/A
- Industry
- BSRR Major Banks
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BSRR Finance
- RGNX Health Care
- Exchange
- BSRR Nasdaq
- RGNX Nasdaq
- Market Cap
- BSRR 425.4M
- RGNX 387.0M
- IPO Year
- BSRR 1994
- RGNX 2015
- Fundamental
- Price
- BSRR $26.62
- RGNX $8.75
- Analyst Decision
- BSRR Hold
- RGNX Strong Buy
- Analyst Count
- BSRR 2
- RGNX 8
- Target Price
- BSRR $35.00
- RGNX $31.75
- AVG Volume (30 Days)
- BSRR 38.3K
- RGNX 1.0M
- Earning Date
- BSRR 04-29-2025
- RGNX 05-07-2025
- Dividend Yield
- BSRR 3.63%
- RGNX N/A
- EPS Growth
- BSRR 19.49
- RGNX N/A
- EPS
- BSRR 2.82
- RGNX N/A
- Revenue
- BSRR $146,758,000.00
- RGNX $83,328,000.00
- Revenue This Year
- BSRR $7.75
- RGNX $285.14
- Revenue Next Year
- BSRR $4.30
- RGNX N/A
- P/E Ratio
- BSRR $9.07
- RGNX N/A
- Revenue Growth
- BSRR 5.49
- RGNX N/A
- 52 Week Low
- BSRR $17.70
- RGNX $5.04
- 52 Week High
- BSRR $35.13
- RGNX $17.99
- Technical
- Relative Strength Index (RSI)
- BSRR 55.02
- RGNX 63.39
- Support Level
- BSRR $24.92
- RGNX $5.85
- Resistance Level
- BSRR $25.86
- RGNX $6.83
- Average True Range (ATR)
- BSRR 1.45
- RGNX 0.66
- MACD
- BSRR 0.26
- RGNX 0.22
- Stochastic Oscillator
- BSRR 92.76
- RGNX 96.43
About BSRR Sierra Bancorp
Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural, and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.